MST1/Hippo promoter gene methylation predicts poor survival in patients with malignant pleural mesothelioma in the IFCT-GFPC-0701 MAPS Phase 3 trial

  • Etude concernée: MAPS
  • Auteurs / Authors: Maille E, Brosseau S, Hanoux V, Creveuil C, Danel C, Bergot E, Scherpereel A, Mazières J, Margery J, Greillier L, Audigier-Valette C, Moro-Sibilot D, Molinier O, Corre R, Monnet I, Gounant V, Langlais A, Morin F, Levallet G, Zalcman G
  • Journal / Conference: British Journal of cancer
  • Année / Year: 2019
  • PMID: 30739911
  • Lien vers la publication: https://www.ncbi.nlm.nih.gov/pubmed/30739911
  • PDF: MST1hippo_in_MAPS_BJC_2019.pdf